We would like to thank all attendees of the ASHP Summer Meetings who stopped by to see us. Having the opportunity to discuss our compliance solutions, in-person, is one that we do not take for granted.
Since our foundation, ConsortiEX has aimed to deliver highly innovative IT systems for hospitals and their affiliated networks. A crucial part of that goal was a seamlessly integrated solution that would satisfy the need for both anticipatory batch and patient specific compounding. We have achieved this with our[...]
ConsortiEX will be shipping up to Boston for this year’s ASHP Summer Meeting. We encourage you to stop at Booth 201 for an in-person look at how you can use our intuitive DQSA Compliance solutions to enhance patient safety, ensure quality control and simplify your compliance needs.
ConsortiEX is proud to announce T3 verification, the newest feature to be added to our DSCSA Compliance as a Service (CaaS) module. The T3 Verification process gives pharmacies maximum visibility to all T3 transactions, both electronic and paper, received by their pharmacy.
The FDA released a finalized questions and answers guidance on data integrity compliance. The FDA guidance adheres to requirements under current good manufacturing practice ( cGMP) for drugs and biologics.
The FDA recently issued a draft guidance regarding verification* systems in accordance with the Drug Supply Chain Security Act (DSCSA).
We want to thank everybody who came to visit our booth at this year’s ASHP Midyear Clinical Meeting & Exhibition. We always appreciate the opportunity to show off our products to the people who need them most.
At ConsortiEX, we work diligently to create solutions designed specifically for the unique needs of health system pharmacies. The result is our Assure-Trak® IV Workflow Management Dynamic Patient Specific Compounding application a dynamically configurable IV Workflow solution to enhance patient safety and optimize[...]
Just last week, ConsortiEX proudly announced our new InsightRX Passive Audit Monitoring module.
Today, cost and quality issues surrounding compounded sterile preparations (CSP’s) have nearly every major health system investigating what it takes to re-insource production. Most are looking at a hub and spoke approach, where their central-fill Batch Compounding can support the CSP production needs of all the[...]